data_2epr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2epr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.3 p -167.7 143.64 4.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 68.8 p -72.33 -58.68 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.3 6.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.0 p -120.18 -59.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 m -105.03 166.87 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.829 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 166.57 -172.51 41.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -92.99 100.95 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.5 t -63.77 138.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -90.1 102.53 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 26.62 4.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -145.83 179.3 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -90.85 -176.32 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.2 p -89.57 153.86 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -92.52 -31.63 8.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -127.08 122.6 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -126.69 70.89 73.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 124.03 10.68 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.7 67.76 3.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 11.9 t -69.1 -30.43 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 69.1 m -81.18 66.52 6.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 169.08 70.21 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.93 58.92 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.719 2.28 . . . . 0.0 112.339 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -59.84 173.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.2 p -163.27 171.29 16.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.507 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 70.0 m -106.63 103.83 13.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.0 p -62.37 138.71 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.36 154.2 25.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.9 p -111.29 179.66 3.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 12.6 p -160.87 -178.97 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.74 -65.41 1.56 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -62.53 173.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 20.0 p -116.09 -30.52 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.6 140.95 55.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -92.06 -41.61 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -132.62 177.83 7.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -77.14 71.39 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 p -133.01 143.48 49.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -142.69 -139.44 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -81.54 177.97 8.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 56.24 73.09 0.87 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.576 0.703 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -30.09 22.89 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 2.254 . . . . 0.0 112.396 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -87.42 131.38 34.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.9 m -86.73 168.55 13.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.4 m -68.35 156.38 37.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.62 173.52 46.94 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -176.98 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.34 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.6 m -101.6 135.97 42.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.838 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 8.5 t -134.94 119.01 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.477 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 27.0 t -141.54 125.8 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.2 m -96.6 -177.88 4.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -142.98 140.88 10.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.8 m -129.96 53.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 16.0 m -59.97 160.17 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 158.47 120.02 0.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -73.89 82.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.8 t -91.99 147.8 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -62.56 112.31 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -100.07 165.99 11.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.58 177.87 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -67.97 177.69 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.0 p -73.87 -176.16 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.12 38.77 3.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.75 153.72 26.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -134.92 72.69 67.76 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 78.84 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.653 2.236 . . . . 0.0 112.345 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -171.6 120.66 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -86.45 124.05 32.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.838 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.7 p -85.48 163.69 18.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 141.62 73.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -173.82 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 47.5 t -143.65 166.99 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.6 t -114.56 151.54 33.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.5 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 88.7 p -169.38 119.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 65.1 p -89.86 135.46 33.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.835 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -91.37 -176.89 43.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 10.0 t -104.46 -64.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.8 m 57.81 45.1 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -107.44 -21.7 7.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -167.55 135.79 2.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 65.8 p -106.06 104.39 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -170.18 148.32 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.86 152.9 50.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.52 179.46 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.94 82.85 8.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.1 m -77.58 -35.5 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 143.21 52.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.71 130.53 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -130.49 68.88 81.93 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -41.19 4.43 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.274 . . . . 0.0 112.297 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -105.34 82.87 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 19.2 p -66.39 142.25 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 t -120.56 164.06 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -113.2 75.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.48 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -72.05 101.53 2.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.9 p -59.13 123.57 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.096 -0.836 . . . . 0.0 112.461 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.73 139.19 55.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.0 p -61.62 128.04 34.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -94.0 114.77 4.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 11.1 p -122.32 144.97 48.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 38.2 m -108.28 -175.98 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -72.39 -175.97 27.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.458 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -54.33 116.07 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.393 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -103.02 94.69 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -75.75 116.76 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -73.65 93.61 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.91 -179.01 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -67.26 129.03 38.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.1 m -83.2 165.64 19.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.56 -48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -108.12 178.68 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -128.61 70.46 80.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 92.89 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -153.0 115.88 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 96.8 p -65.94 96.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 17.0 t -112.94 39.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -81.71 -75.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.97 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.713 2.276 . . . . 0.0 112.322 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 87.3 p -105.65 172.32 6.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.29 99.1 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 119.114 -0.826 . . . . 0.0 112.466 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 91.0 p -67.59 -175.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 18.0 m -132.69 56.57 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.8 158.13 29.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.531 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.0 m -122.82 123.38 40.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 66.3 p -146.35 134.87 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.02 150.44 7.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 32.27 4.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 44.9 p -75.04 149.5 39.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 56.15 39.86 30.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 170.1 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -167.09 177.96 5.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -67.59 173.27 4.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.2 t -85.81 -51.56 6.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.847 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.53 70.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -100.1 37.0 1.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -121.53 71.95 27.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.42 10.79 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -64.65 152.76 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.42 137.24 52.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.869 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 58.2 p -152.64 135.01 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 161.43 -169.86 37.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 174.27 9.77 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.291 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.3 m -101.79 67.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 12.2 t -135.23 158.22 44.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.491 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 32.9 m -125.62 129.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.903 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 34.0 t -114.18 143.56 44.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 53.5 51.58 47.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t -70.58 147.94 48.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 31.0 m -91.96 114.58 27.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 157.04 171.02 22.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -71.12 102.5 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.6 t -124.86 -39.35 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -169.13 121.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -100.1 28.38 4.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.89 -179.29 6.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -55.55 138.93 45.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 23.3 t -90.12 89.88 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -60.15 166.6 10.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 35.97 2.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 73.65 0.76 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 157.94 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.22 130.43 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.1 t -97.82 144.66 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 t -168.81 146.72 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -147.42 172.28 27.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 154.75 67.33 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.341 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 83.7 p -91.1 86.82 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 67.4 p -101.22 123.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.473 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 16.4 p -104.4 -40.34 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.7 m -84.21 67.4 9.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -69.56 -113.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 46.2 t -115.57 90.93 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.3 m -114.33 121.82 44.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -112.17 174.07 16.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -60.93 -60.49 3.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.5 t -157.34 140.96 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -66.3 113.62 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 37.76 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.95 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.11 169.65 7.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -63.89 164.38 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.1 t -107.59 -50.84 3.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.845 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.73 73.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -59.59 116.94 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -136.24 69.41 62.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -48.02 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -81.35 138.48 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.0 t -116.4 104.88 11.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 33.1 p -106.21 -38.84 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.36 175.68 20.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 172.34 12.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.0 p -149.49 123.65 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.5 m -82.48 79.02 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.517 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 7.1 t -154.98 148.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.4 t -154.31 121.32 5.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 131.43 57.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -67.38 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.857 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 2.8 p -98.01 132.39 43.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -68.57 -91.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -75.22 76.85 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 t -53.21 -29.04 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -146.46 139.14 25.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -83.66 -69.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.83 177.42 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -61.2 173.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.5 t -126.03 -59.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 164.43 -123.14 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -107.25 41.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -133.63 70.93 75.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 172.25 13.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -71.94 156.31 39.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 14.2 m -116.27 -49.28 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.2 m -111.17 176.53 4.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 139.9 74.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -18.08 37.24 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.665 2.244 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -139.33 123.25 17.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 m -134.4 -176.65 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.47 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.3 t -134.04 142.71 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.8 t -101.48 116.25 32.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -93.17 -57.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.523 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.84 31.03 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 88.7 p -119.93 -46.84 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 66.96 -148.06 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -171.45 153.06 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -135.25 161.51 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -103.27 151.25 22.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -81.05 -25.92 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.95 -176.95 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -64.17 149.66 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -72.55 127.72 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.04 166.03 44.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.77 101.45 14.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -130.74 72.79 81.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -179.22 2.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.252 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.87 -47.68 3.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -129.65 125.88 37.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.4 t -89.95 -40.11 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 171.89 -169.89 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.48 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.372 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 t -130.04 121.33 26.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.8 m -119.48 165.49 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 119.114 -0.825 . . . . 0.0 112.481 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.5 t -145.52 166.92 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.6 m -122.23 171.3 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -63.37 -29.44 74.54 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 7.6 p -122.86 61.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 41.6 t -55.48 -66.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.41 45.43 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -121.93 143.45 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 34.8 p -133.32 170.09 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -142.69 150.26 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.48 24.56 5.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -103.75 168.85 8.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -55.15 135.18 49.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.0 t -99.39 78.2 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.4 113.87 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.49 162.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.894 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -119.67 70.62 13.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.27 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -166.54 -178.55 4.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.8 m -85.35 137.06 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.9 p -86.88 -178.77 6.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 177.07 68.19 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -30.7 21.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.314 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.3 m 52.13 31.29 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.5 p -146.5 159.5 43.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.473 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.4 m -102.26 165.74 10.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 17.1 m -114.06 150.73 33.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.1 122.12 2.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.4 t -158.82 144.63 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.3 m -84.66 -62.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -78.18 69.98 2.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -66.58 -26.89 67.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 p -64.84 152.43 42.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 47.2 mtm-85 -81.8 154.28 26.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -105.33 -58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 -177.58 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.98 157.93 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.1 m -123.5 117.5 25.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.64 37.72 3.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.13 99.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -171.39 71.11 0.5 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 159.79 52.09 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -110.5 169.72 8.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.6 t -122.5 102.43 8.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 t -56.48 153.45 10.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 170.46 -70.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.81 36.27 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.335 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.2 m -59.38 179.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.7 t -129.81 132.17 46.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.178 -0.79 . . . . 0.0 112.431 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.4 t -68.12 133.24 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.89 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 10.5 t -105.91 -29.46 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -168.11 65.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.1 t -77.55 169.63 17.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 7.0 t -126.05 29.89 5.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -167.41 135.76 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.32 120.65 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 69.8 p -112.67 70.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.85 120.36 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.92 -46.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.49 174.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -53.84 -41.75 67.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.2 m -57.01 156.96 6.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 130.43 -82.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.52 41.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -154.99 73.11 5.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -179.23 2.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.282 . . . . 0.0 112.324 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -93.16 139.12 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -90.34 137.37 32.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 47.4 m -88.89 115.74 26.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.29 72.06 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 88.2 p -107.38 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.6 p -81.46 83.59 6.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.504 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 28.8 m -118.75 161.26 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.375 . . . . 0.0 110.872 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.1 p -139.24 165.52 26.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -165.25 63.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.3 p -111.45 127.45 55.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 68.7 p -76.42 173.6 11.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -147.31 84.88 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -94.13 115.04 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -123.38 147.53 46.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -70.58 146.9 49.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -88.06 96.5 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -123.79 173.79 7.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -62.88 159.97 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.4 t -76.31 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.16 156.55 19.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -93.55 90.13 6.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -55.61 160.67 3.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 103.38 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.698 2.266 . . . . 0.0 112.367 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -53.06 147.91 8.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.2 m -66.42 134.7 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 23.4 t -94.46 103.06 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -60.06 174.47 4.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 177.1 5.93 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 15.0 p -69.73 -178.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.3 m -148.51 126.03 11.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.469 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.5 t -85.37 85.21 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.86 55.77 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 79.5 61.77 2.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.8 m -70.17 104.45 2.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.5 p -158.82 152.73 23.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.41 163.24 17.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -79.64 -26.24 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 p -85.41 122.08 29.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 47.77 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.83 176.89 7.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -70.96 99.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -165.57 160.33 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.08 92.66 0.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -84.46 -60.49 2.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.2 160.65 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 130.43 19.41 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -114.4 159.82 19.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.4 t -172.18 130.83 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 61.5 m -121.06 176.44 5.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.46 -70.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 95.13 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.313 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 157.22 47.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.4 m -123.23 112.72 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.436 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -69.49 138.28 53.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 2.2 m -94.84 -62.4 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 151.47 -57.27 0.44 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 45.3 t -78.08 153.08 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 49.1 p -67.46 -43.49 80.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 145.97 -109.6 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -77.09 118.16 19.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.9 p -88.52 -54.55 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.58 48.81 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -66.38 -30.79 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -106.68 -178.67 3.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -78.64 158.07 28.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.8 t -143.49 147.5 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.22 82.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -94.39 135.43 35.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.944 0.402 . . . . 0.0 110.903 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -103.79 160.66 25.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.515 0.674 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.26 35.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.37 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -161.06 145.35 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 18.2 p -141.13 144.92 35.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 45.5 m -134.64 166.54 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -63.22 -178.17 4.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 158.67 56.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.249 . . . . 0.0 112.305 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 7.7 t -143.1 131.29 21.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.851 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 55.1 m -67.22 104.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.504 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.9 m -80.36 148.69 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.7 t -127.24 75.25 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.37 118.35 1.63 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.1 m -116.49 113.75 23.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.836 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 72.9 m -159.62 157.26 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 70.87 -170.96 45.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -113.06 176.52 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.9 p -120.12 42.87 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -128.85 83.48 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.01 107.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -145.15 176.66 9.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.5 140.16 58.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 137.15 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 156.43 -167.14 33.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.52 155.5 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.44 160.66 25.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.528 0.68 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.721 2.281 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -118.53 162.29 18.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.9 t -90.9 143.61 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 42.0 m -126.44 139.4 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.79 170.16 43.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.44 47.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.306 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 49.3 m -136.22 178.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.0 t -161.5 112.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.513 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 64.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 88.1 p -174.48 133.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 141.33 162.23 9.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.4 m -132.49 128.39 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.2 p -94.53 -48.67 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -146.38 -161.27 9.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 56.6 53.72 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.9 m -110.1 42.83 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -160.66 138.77 9.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -115.56 -74.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.89 173.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -68.76 163.37 24.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.1 m -95.34 153.0 17.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.58 36.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.54 84.57 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -98.73 160.68 27.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.556 0.694 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 111.82 2.92 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -111.77 26.31 10.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 22.9 t -126.69 143.98 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.8 m -80.9 148.08 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -139.12 -75.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -43.56 2.51 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 2.3 t -156.67 147.99 22.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -96.3 96.44 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 29.1 t -145.89 130.55 17.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 49.3 m -71.96 -66.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 175.97 124.77 0.84 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.446 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 38.1 m -71.53 -60.32 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 23.1 t -166.78 129.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -143.22 -151.75 5.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 104.29 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.912 0.386 . . . . 0.0 110.883 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 m -126.71 108.34 10.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -110.97 87.47 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.03 143.23 55.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -128.81 178.12 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -52.05 164.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -72.02 156.9 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -58.09 164.78 7.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -96.27 165.04 12.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.49 68.91 9.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.92 3.28 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.74 112.42 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 m 60.35 46.94 9.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 12.9 t -141.5 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -141.74 70.94 0.42 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 126.92 13.83 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 43.6 p -130.48 50.58 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 p -53.05 -64.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.449 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 8.5 m -92.74 -43.62 8.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 70.1 m -103.9 75.91 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 160.78 -128.87 2.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.2 m 56.52 45.03 23.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 4.3 t -99.16 -30.32 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 69.76 -155.21 53.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.444 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -61.47 120.95 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.4 t -108.63 -33.49 7.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -92.22 167.45 12.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.57 -28.8 7.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -135.57 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.92 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -54.63 143.33 25.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.0 p -122.1 165.85 15.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -159.71 144.87 10.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.57 157.45 20.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -128.62 159.32 68.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.611 0.719 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 153.52 68.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -70.87 149.65 46.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.0 p -131.16 95.74 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -98.56 124.38 43.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 154.1 173.63 23.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.57 10.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.672 2.248 . . . . 0.0 112.315 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 p -101.73 91.0 4.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.5 m -143.37 138.45 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.474 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 370' ' ' LEU . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 355' ' ' VAL . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 370' ' ' LEU . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 355' ' ' VAL . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.862 HG11 HD22 ' A' ' 370' ' ' LEU . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 355' ' ' VAL . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' A' ' 370' ' ' LEU . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.597 HD22 ' CG1' ' A' ' 355' ' ' VAL . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.647 ' OD1' HG12 ' A' ' 367' ' ' VAL . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 370' ' ' LEU . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 355' ' ' VAL . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 375' ' ' LEU . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 372' ' ' ARG . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 370' ' ' LEU . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 355' ' ' VAL . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.508 ' HG2' HD12 ' A' ' 375' ' ' LEU . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.508 HD12 ' HG2' ' A' ' 372' ' ' ARG . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 363' ' ' ILE . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 356' ' ' ALA . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 355' ' ' VAL . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.549 ' HA ' HD12 ' A' ' 375' ' ' LEU . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 372' ' ' ARG . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 355' ' ' VAL . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 370' ' ' LEU . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.414 ' C ' HG21 ' A' ' 355' ' ' VAL . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 355' ' ' VAL . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 370' ' ' LEU . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 355' ' ' VAL . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.64 HG11 HD22 ' A' ' 370' ' ' LEU . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.64 HD22 HG11 ' A' ' 355' ' ' VAL . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.689 HG11 HD22 ' A' ' 370' ' ' LEU . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.689 HD22 HG11 ' A' ' 355' ' ' VAL . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.648 HG11 HD22 ' A' ' 370' ' ' LEU . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.577 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 355' ' ' VAL . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ASN . . . . . 0.577 ' OD1' HG12 ' A' ' 367' ' ' VAL . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.541 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.541 HD22 HG11 ' A' ' 355' ' ' VAL . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 375' ' ' LEU . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 372' ' ' ARG . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.598 ' CG1' HD22 ' A' ' 370' ' ' LEU . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.598 HD22 ' CG1' ' A' ' 355' ' ' VAL . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.78 ' HA ' HD12 ' A' ' 375' ' ' LEU . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 372' ' ' ARG . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 355' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 370' ' ' LEU . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 355' ' ' VAL . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.804 ' HA ' HD12 ' A' ' 375' ' ' LEU . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 372' ' ' ARG . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.3 p -167.7 143.64 4.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 68.8 p -72.33 -58.68 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.3 6.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.0 p -120.18 -59.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 m -105.03 166.87 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.829 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 166.57 -172.51 41.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -92.99 100.95 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.5 t -63.77 138.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -90.1 102.53 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 26.62 4.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -145.83 179.3 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 370' ' ' LEU . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 355' ' ' VAL . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -90.85 -176.32 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.2 p -89.57 153.86 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -92.52 -31.63 8.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -127.08 122.6 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -126.69 70.89 73.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 124.03 10.68 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.7 67.76 3.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 11.9 t -69.1 -30.43 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 69.1 m -81.18 66.52 6.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 169.08 70.21 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.93 58.92 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.719 2.28 . . . . 0.0 112.339 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -59.84 173.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.2 p -163.27 171.29 16.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.507 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 70.0 m -106.63 103.83 13.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.0 p -62.37 138.71 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.36 154.2 25.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.9 p -111.29 179.66 3.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 12.6 p -160.87 -178.97 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.74 -65.41 1.56 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -62.53 173.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 20.0 p -116.09 -30.52 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.6 140.95 55.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -92.06 -41.61 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -132.62 177.83 7.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 370' ' ' LEU . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 355' ' ' VAL . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -77.14 71.39 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 p -133.01 143.48 49.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -142.69 -139.44 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -81.54 177.97 8.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 56.24 73.09 0.87 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.576 0.703 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -30.09 22.89 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 2.254 . . . . 0.0 112.396 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -87.42 131.38 34.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.9 m -86.73 168.55 13.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.4 m -68.35 156.38 37.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.62 173.52 46.94 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -176.98 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.34 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.6 m -101.6 135.97 42.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.838 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 8.5 t -134.94 119.01 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.477 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 27.0 t -141.54 125.8 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.2 m -96.6 -177.88 4.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -142.98 140.88 10.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.8 m -129.96 53.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 16.0 m -59.97 160.17 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 158.47 120.02 0.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -73.89 82.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.8 t -91.99 147.8 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -62.56 112.31 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -100.07 165.99 11.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.58 177.87 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.862 HG11 HD22 ' A' ' 370' ' ' LEU . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 355' ' ' VAL . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -67.97 177.69 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.0 p -73.87 -176.16 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.12 38.77 3.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.75 153.72 26.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -134.92 72.69 67.76 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 78.84 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.653 2.236 . . . . 0.0 112.345 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -171.6 120.66 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -86.45 124.05 32.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.838 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.7 p -85.48 163.69 18.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 141.62 73.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -173.82 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 47.5 t -143.65 166.99 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.6 t -114.56 151.54 33.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.5 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 88.7 p -169.38 119.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 65.1 p -89.86 135.46 33.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.835 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -91.37 -176.89 43.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 10.0 t -104.46 -64.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.8 m 57.81 45.1 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -107.44 -21.7 7.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -167.55 135.79 2.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 65.8 p -106.06 104.39 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -170.18 148.32 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.86 152.9 50.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.52 179.46 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' A' ' 370' ' ' LEU . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.597 HD22 ' CG1' ' A' ' 355' ' ' VAL . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.647 ' OD1' HG12 ' A' ' 367' ' ' VAL . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.94 82.85 8.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.1 m -77.58 -35.5 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 143.21 52.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.71 130.53 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -130.49 68.88 81.93 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -41.19 4.43 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.274 . . . . 0.0 112.297 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -105.34 82.87 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 19.2 p -66.39 142.25 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 t -120.56 164.06 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -113.2 75.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.48 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -72.05 101.53 2.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.9 p -59.13 123.57 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.096 -0.836 . . . . 0.0 112.461 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.73 139.19 55.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.0 p -61.62 128.04 34.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -94.0 114.77 4.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 11.1 p -122.32 144.97 48.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 38.2 m -108.28 -175.98 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -72.39 -175.97 27.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.458 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -54.33 116.07 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.393 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -103.02 94.69 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -75.75 116.76 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -73.65 93.61 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.91 -179.01 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 370' ' ' LEU . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 355' ' ' VAL . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 375' ' ' LEU . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 372' ' ' ARG . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -67.26 129.03 38.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.1 m -83.2 165.64 19.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.56 -48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -108.12 178.68 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -128.61 70.46 80.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 92.89 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -153.0 115.88 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 96.8 p -65.94 96.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 17.0 t -112.94 39.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -81.71 -75.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.97 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.713 2.276 . . . . 0.0 112.322 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 87.3 p -105.65 172.32 6.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.29 99.1 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 119.114 -0.826 . . . . 0.0 112.466 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 91.0 p -67.59 -175.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 18.0 m -132.69 56.57 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.8 158.13 29.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.531 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.0 m -122.82 123.38 40.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 66.3 p -146.35 134.87 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.02 150.44 7.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 32.27 4.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 44.9 p -75.04 149.5 39.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 56.15 39.86 30.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 170.1 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -167.09 177.96 5.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 370' ' ' LEU . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 355' ' ' VAL . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.508 ' HG2' HD12 ' A' ' 375' ' ' LEU . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.508 HD12 ' HG2' ' A' ' 372' ' ' ARG . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -67.59 173.27 4.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.2 t -85.81 -51.56 6.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.847 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.53 70.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -100.1 37.0 1.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -121.53 71.95 27.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.42 10.79 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -64.65 152.76 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.42 137.24 52.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.869 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 58.2 p -152.64 135.01 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 161.43 -169.86 37.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 174.27 9.77 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.291 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.3 m -101.79 67.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 12.2 t -135.23 158.22 44.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.491 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 32.9 m -125.62 129.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.903 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 34.0 t -114.18 143.56 44.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 53.5 51.58 47.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t -70.58 147.94 48.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 31.0 m -91.96 114.58 27.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 157.04 171.02 22.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -71.12 102.5 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.6 t -124.86 -39.35 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -169.13 121.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -100.1 28.38 4.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.89 -179.29 6.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 363' ' ' ILE . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 356' ' ' ALA . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -55.55 138.93 45.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 23.3 t -90.12 89.88 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -60.15 166.6 10.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 35.97 2.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 73.65 0.76 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 157.94 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.22 130.43 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.1 t -97.82 144.66 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 t -168.81 146.72 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -147.42 172.28 27.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 154.75 67.33 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.341 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 83.7 p -91.1 86.82 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 67.4 p -101.22 123.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.473 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 16.4 p -104.4 -40.34 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.7 m -84.21 67.4 9.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -69.56 -113.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 46.2 t -115.57 90.93 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.3 m -114.33 121.82 44.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -112.17 174.07 16.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -60.93 -60.49 3.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.5 t -157.34 140.96 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -66.3 113.62 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 37.76 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.95 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.11 169.65 7.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -63.89 164.38 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.1 t -107.59 -50.84 3.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.845 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.73 73.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -59.59 116.94 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -136.24 69.41 62.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -48.02 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -81.35 138.48 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.0 t -116.4 104.88 11.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 33.1 p -106.21 -38.84 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.36 175.68 20.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 172.34 12.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.0 p -149.49 123.65 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.5 m -82.48 79.02 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.517 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 7.1 t -154.98 148.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.4 t -154.31 121.32 5.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 131.43 57.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -67.38 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.857 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 2.8 p -98.01 132.39 43.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -68.57 -91.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -75.22 76.85 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 t -53.21 -29.04 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -146.46 139.14 25.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -83.66 -69.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.83 177.42 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 355' ' ' VAL . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.549 ' HA ' HD12 ' A' ' 375' ' ' LEU . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 372' ' ' ARG . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -61.2 173.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.5 t -126.03 -59.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 164.43 -123.14 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -107.25 41.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -133.63 70.93 75.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 172.25 13.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -71.94 156.31 39.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 14.2 m -116.27 -49.28 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.2 m -111.17 176.53 4.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 139.9 74.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -18.08 37.24 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.665 2.244 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -139.33 123.25 17.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 m -134.4 -176.65 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.47 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.3 t -134.04 142.71 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.8 t -101.48 116.25 32.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -93.17 -57.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.523 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.84 31.03 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 88.7 p -119.93 -46.84 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 66.96 -148.06 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -171.45 153.06 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -135.25 161.51 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -103.27 151.25 22.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -81.05 -25.92 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.95 -176.95 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 355' ' ' VAL . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -64.17 149.66 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -72.55 127.72 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.04 166.03 44.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.77 101.45 14.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -130.74 72.79 81.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -179.22 2.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.252 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.87 -47.68 3.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -129.65 125.88 37.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.4 t -89.95 -40.11 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 171.89 -169.89 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.48 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.372 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 t -130.04 121.33 26.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.8 m -119.48 165.49 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 119.114 -0.825 . . . . 0.0 112.481 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.5 t -145.52 166.92 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.6 m -122.23 171.3 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -63.37 -29.44 74.54 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 7.6 p -122.86 61.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 41.6 t -55.48 -66.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.41 45.43 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -121.93 143.45 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 34.8 p -133.32 170.09 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -142.69 150.26 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.48 24.56 5.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -103.75 168.85 8.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -55.15 135.18 49.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.0 t -99.39 78.2 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.4 113.87 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.49 162.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.894 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -119.67 70.62 13.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.27 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -166.54 -178.55 4.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.8 m -85.35 137.06 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.9 p -86.88 -178.77 6.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 177.07 68.19 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -30.7 21.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.314 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.3 m 52.13 31.29 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.5 p -146.5 159.5 43.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.473 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.4 m -102.26 165.74 10.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 17.1 m -114.06 150.73 33.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.1 122.12 2.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.4 t -158.82 144.63 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.3 m -84.66 -62.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -78.18 69.98 2.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -66.58 -26.89 67.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 p -64.84 152.43 42.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 47.2 mtm-85 -81.8 154.28 26.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -105.33 -58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 -177.58 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 370' ' ' LEU . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.414 ' C ' HG21 ' A' ' 355' ' ' VAL . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 355' ' ' VAL . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.98 157.93 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.1 m -123.5 117.5 25.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.64 37.72 3.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.13 99.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -171.39 71.11 0.5 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 159.79 52.09 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -110.5 169.72 8.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.6 t -122.5 102.43 8.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 t -56.48 153.45 10.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 170.46 -70.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.81 36.27 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.335 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.2 m -59.38 179.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.7 t -129.81 132.17 46.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.178 -0.79 . . . . 0.0 112.431 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.4 t -68.12 133.24 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.89 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 10.5 t -105.91 -29.46 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -168.11 65.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.1 t -77.55 169.63 17.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 7.0 t -126.05 29.89 5.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -167.41 135.76 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.32 120.65 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 69.8 p -112.67 70.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.85 120.36 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.92 -46.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.49 174.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 370' ' ' LEU . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 355' ' ' VAL . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -53.84 -41.75 67.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.2 m -57.01 156.96 6.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 130.43 -82.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.52 41.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -154.99 73.11 5.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -179.23 2.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.282 . . . . 0.0 112.324 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -93.16 139.12 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -90.34 137.37 32.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 47.4 m -88.89 115.74 26.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.29 72.06 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 88.2 p -107.38 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.6 p -81.46 83.59 6.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.504 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 28.8 m -118.75 161.26 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.375 . . . . 0.0 110.872 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.1 p -139.24 165.52 26.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -165.25 63.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.3 p -111.45 127.45 55.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 68.7 p -76.42 173.6 11.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -147.31 84.88 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -94.13 115.04 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -123.38 147.53 46.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -70.58 146.9 49.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -88.06 96.5 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -123.79 173.79 7.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.64 HG11 HD22 ' A' ' 370' ' ' LEU . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.64 HD22 HG11 ' A' ' 355' ' ' VAL . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -62.88 159.97 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.4 t -76.31 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.16 156.55 19.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -93.55 90.13 6.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -55.61 160.67 3.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 103.38 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.698 2.266 . . . . 0.0 112.367 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -53.06 147.91 8.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.2 m -66.42 134.7 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 23.4 t -94.46 103.06 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -60.06 174.47 4.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 177.1 5.93 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 15.0 p -69.73 -178.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.3 m -148.51 126.03 11.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.469 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.5 t -85.37 85.21 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.86 55.77 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 79.5 61.77 2.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.8 m -70.17 104.45 2.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.5 p -158.82 152.73 23.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.41 163.24 17.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -79.64 -26.24 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 p -85.41 122.08 29.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 47.77 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.83 176.89 7.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.689 HG11 HD22 ' A' ' 370' ' ' LEU . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.689 HD22 HG11 ' A' ' 355' ' ' VAL . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -70.96 99.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -165.57 160.33 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.08 92.66 0.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -84.46 -60.49 2.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.2 160.65 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 130.43 19.41 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -114.4 159.82 19.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.4 t -172.18 130.83 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 61.5 m -121.06 176.44 5.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.46 -70.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 95.13 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.313 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 157.22 47.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.4 m -123.23 112.72 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.436 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -69.49 138.28 53.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 2.2 m -94.84 -62.4 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 151.47 -57.27 0.44 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 45.3 t -78.08 153.08 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 49.1 p -67.46 -43.49 80.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 145.97 -109.6 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -77.09 118.16 19.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.9 p -88.52 -54.55 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.58 48.81 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -66.38 -30.79 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -106.68 -178.67 3.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.648 HG11 HD22 ' A' ' 370' ' ' LEU . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.577 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 355' ' ' VAL . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.577 ' OD1' HG12 ' A' ' 367' ' ' VAL . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -78.64 158.07 28.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.8 t -143.49 147.5 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.22 82.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -94.39 135.43 35.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.944 0.402 . . . . 0.0 110.903 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -103.79 160.66 25.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.515 0.674 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.26 35.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.37 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -161.06 145.35 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 18.2 p -141.13 144.92 35.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 45.5 m -134.64 166.54 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -63.22 -178.17 4.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 158.67 56.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.249 . . . . 0.0 112.305 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 7.7 t -143.1 131.29 21.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.851 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 55.1 m -67.22 104.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.504 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.9 m -80.36 148.69 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.7 t -127.24 75.25 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.37 118.35 1.63 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.1 m -116.49 113.75 23.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.836 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 72.9 m -159.62 157.26 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 70.87 -170.96 45.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -113.06 176.52 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.9 p -120.12 42.87 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -128.85 83.48 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.01 107.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -145.15 176.66 9.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.5 140.16 58.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 137.15 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 156.43 -167.14 33.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.52 155.5 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.44 160.66 25.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.528 0.68 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.721 2.281 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -118.53 162.29 18.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.9 t -90.9 143.61 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 42.0 m -126.44 139.4 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.79 170.16 43.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.44 47.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.306 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 49.3 m -136.22 178.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.0 t -161.5 112.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.513 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 64.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 88.1 p -174.48 133.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 141.33 162.23 9.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.4 m -132.49 128.39 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.2 p -94.53 -48.67 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -146.38 -161.27 9.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 56.6 53.72 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.9 m -110.1 42.83 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -160.66 138.77 9.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -115.56 -74.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -54.89 173.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.541 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.541 HD22 HG11 ' A' ' 355' ' ' VAL . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 375' ' ' LEU . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 372' ' ' ARG . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -68.76 163.37 24.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.1 m -95.34 153.0 17.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.58 36.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.54 84.57 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -98.73 160.68 27.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.556 0.694 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 111.82 2.92 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -111.77 26.31 10.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 22.9 t -126.69 143.98 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.8 m -80.9 148.08 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -139.12 -75.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -43.56 2.51 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 2.3 t -156.67 147.99 22.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -96.3 96.44 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 29.1 t -145.89 130.55 17.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 49.3 m -71.96 -66.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 175.97 124.77 0.84 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.446 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 38.1 m -71.53 -60.32 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 23.1 t -166.78 129.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -143.22 -151.75 5.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 104.29 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.912 0.386 . . . . 0.0 110.883 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 m -126.71 108.34 10.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -110.97 87.47 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.03 143.23 55.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -128.81 178.12 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.598 ' CG1' HD22 ' A' ' 370' ' ' LEU . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.598 HD22 ' CG1' ' A' ' 355' ' ' VAL . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.78 ' HA ' HD12 ' A' ' 375' ' ' LEU . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 372' ' ' ARG . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -52.05 164.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -72.02 156.9 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -58.09 164.78 7.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -96.27 165.04 12.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.49 68.91 9.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.92 3.28 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.74 112.42 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 m 60.35 46.94 9.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 12.9 t -141.5 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -141.74 70.94 0.42 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 126.92 13.83 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 43.6 p -130.48 50.58 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 p -53.05 -64.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.449 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 8.5 m -92.74 -43.62 8.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 70.1 m -103.9 75.91 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 160.78 -128.87 2.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.2 m 56.52 45.03 23.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 4.3 t -99.16 -30.32 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 69.76 -155.21 53.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.444 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -61.47 120.95 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.4 t -108.63 -33.49 7.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -92.22 167.45 12.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.57 -28.8 7.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.57 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 370' ' ' LEU . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 355' ' ' VAL . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.804 ' HA ' HD12 ' A' ' 375' ' ' LEU . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 372' ' ' ARG . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -54.63 143.33 25.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.0 p -122.1 165.85 15.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -159.71 144.87 10.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.57 157.45 20.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -128.62 159.32 68.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.611 0.719 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 153.52 68.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -70.87 149.65 46.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.0 p -131.16 95.74 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -98.56 124.38 43.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 154.1 173.63 23.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.57 10.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.672 2.248 . . . . 0.0 112.315 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 p -101.73 91.0 4.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.5 m -143.37 138.45 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.474 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.846 0.355 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 370' ' ' LEU . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 355' ' ' VAL . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.873 0.368 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 370' ' ' LEU . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 355' ' ' VAL . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.862 HG11 HD22 ' A' ' 370' ' ' LEU . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 355' ' ' VAL . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.883 0.373 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' A' ' 370' ' ' LEU . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.597 HD22 ' CG1' ' A' ' 355' ' ' VAL . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.647 ' OD1' HG12 ' A' ' 367' ' ' VAL . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 370' ' ' LEU . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 355' ' ' VAL . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 375' ' ' LEU . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 372' ' ' ARG . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 370' ' ' LEU . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 355' ' ' VAL . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.508 ' HG2' HD12 ' A' ' 375' ' ' LEU . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.508 HD12 ' HG2' ' A' ' 372' ' ' ARG . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.893 0.377 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 363' ' ' ILE . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 356' ' ' ALA . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 355' ' ' VAL . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.549 ' HA ' HD12 ' A' ' 375' ' ' LEU . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 372' ' ' ARG . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 355' ' ' VAL . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.832 0.349 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 370' ' ' LEU . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.414 ' C ' HG21 ' A' ' 355' ' ' VAL . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 355' ' ' VAL . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.898 0.38 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 370' ' ' LEU . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 355' ' ' VAL . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.64 HG11 HD22 ' A' ' 370' ' ' LEU . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.64 HD22 HG11 ' A' ' 355' ' ' VAL . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.842 0.353 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.689 HG11 HD22 ' A' ' 370' ' ' LEU . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.689 HD22 HG11 ' A' ' 355' ' ' VAL . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.32 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.648 HG11 HD22 ' A' ' 370' ' ' LEU . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.577 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 355' ' ' VAL . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . 0.577 ' OD1' HG12 ' A' ' 367' ' ' VAL . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.812 0.339 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.541 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.541 HD22 HG11 ' A' ' 355' ' ' VAL . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 375' ' ' LEU . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 372' ' ' ARG . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.598 ' CG1' HD22 ' A' ' 370' ' ' LEU . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.598 HD22 ' CG1' ' A' ' 355' ' ' VAL . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.78 ' HA ' HD12 ' A' ' 375' ' ' LEU . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 372' ' ' ARG . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.884 0.373 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 370' ' ' LEU . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 355' ' ' VAL . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.804 ' HA ' HD12 ' A' ' 375' ' ' LEU . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 372' ' ' ARG . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.3 p -167.7 143.64 4.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 68.8 p -72.33 -58.68 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 84.4 45.3 6.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.0 p -120.18 -59.92 1.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 0.0 110.844 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 15.6 m -105.03 166.87 10.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.829 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 166.57 -172.51 41.82 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -92.99 100.95 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.5 t -63.77 138.69 58.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.11 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -90.1 102.53 15.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 26.62 4.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -145.83 179.3 7.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.516 HG11 HD22 ' A' ' 370' ' ' LEU . 48.3 t -110.4 143.54 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -137.44 115.36 11.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.7 t -77.91 115.37 17.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.49 -26.31 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.2 mt -52.0 -53.76 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.4 p -106.12 -34.27 7.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.26 69.22 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -141.13 168.36 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.74 0.305 . . . . 0.0 110.912 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.6 mm -119.14 144.78 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -138.37 168.81 18.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -74.34 -62.86 1.37 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -138.56 173.15 11.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.51 -30.54 44.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -53.93 -30.57 46.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.945 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -87.39 -35.87 18.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 355' ' ' VAL . 38.2 tp -67.58 -28.66 67.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.878 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -56.41 -44.61 80.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -74.25 -26.21 60.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -75.87 -36.12 59.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -54.9 -26.82 38.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 27.0 mt -52.42 -46.71 66.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 9.3 t -59.08 -30.07 67.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -90.85 -176.32 4.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.2 p -89.57 153.86 20.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -92.52 -31.63 8.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -127.08 122.6 34.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -126.69 70.89 73.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.595 0.712 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 124.03 10.68 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -77.7 67.76 3.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 11.9 t -69.1 -30.43 68.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 69.1 m -81.18 66.52 6.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 169.08 70.21 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.93 58.92 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.719 2.28 . . . . 0.0 112.339 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 5.1 m -59.84 173.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.2 p -163.27 171.29 16.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.507 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 70.0 m -106.63 103.83 13.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.0 p -62.37 138.71 58.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.36 154.2 25.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.495 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.9 p -111.29 179.66 3.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 12.6 p -160.87 -178.97 7.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -83.74 -65.41 1.56 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -62.53 173.2 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.88 0.371 . . . . 0.0 110.867 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 20.0 p -116.09 -30.52 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.6 140.95 55.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -92.06 -41.61 10.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -132.62 177.83 7.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 370' ' ' LEU . 33.9 t -104.18 137.75 31.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.127 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -125.41 96.78 4.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 10.6 t -59.77 111.59 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -82.79 -26.67 31.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.9 mt -52.24 -55.23 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -103.21 -31.08 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 96.61 62.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -138.56 163.1 32.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.22 139.23 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -127.74 164.05 22.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -73.94 -45.66 48.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 52.0 p-10 -157.52 173.59 16.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 82.5 t -65.72 -30.33 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -52.35 -30.6 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -94.02 -27.27 16.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 355' ' ' VAL . 25.2 tp -71.43 -28.75 64.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -55.16 -46.73 75.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.37 -28.32 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.92 -43.26 72.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.4 mtmt -56.45 -27.08 55.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.38 -41.91 98.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 t -61.86 -26.81 68.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -77.14 71.39 3.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.841 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 p -133.01 143.48 49.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -142.69 -139.44 3.59 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -81.54 177.97 8.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 0.0 110.921 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 4.4 mptt 56.24 73.09 0.87 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.576 0.703 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -30.09 22.89 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 2.254 . . . . 0.0 112.396 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -87.42 131.38 34.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.9 m -86.73 168.55 13.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.4 m -68.35 156.38 37.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 80.62 173.52 46.94 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.49 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -176.98 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.696 2.264 . . . . 0.0 112.34 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 4.6 m -101.6 135.97 42.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.838 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 8.5 t -134.94 119.01 17.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.477 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 27.0 t -141.54 125.8 17.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 110.842 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.2 m -96.6 -177.88 4.07 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.822 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -142.98 140.88 10.09 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.8 m -129.96 53.74 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 16.0 m -59.97 160.17 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 158.47 120.02 0.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -73.89 82.74 1.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.87 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.8 t -91.99 147.8 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -62.56 112.31 2.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -100.07 165.99 11.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.58 177.87 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.862 HG11 HD22 ' A' ' 370' ' ' LEU . 24.2 t -111.59 144.24 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.77 96.99 3.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 6.3 t -61.54 111.88 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -84.07 -26.3 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 57.6 mt -52.05 -53.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.15 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.6 p -106.22 -34.22 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.52 74.97 1.1 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.443 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -148.83 164.81 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.26 134.4 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.95 153.14 44.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -63.16 -58.52 6.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -138.54 167.83 21.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.1 t -57.02 -25.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -55.45 -42.17 73.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -75.71 -28.0 58.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 355' ' ' VAL . 30.2 tp -75.46 -29.06 59.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -52.25 -63.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -61.77 -34.34 75.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -64.11 -30.9 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -71.05 -39.6 72.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 72.0 mt -62.55 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.954 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.8 m -71.07 -29.1 64.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -67.97 177.69 2.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.0 p -73.87 -176.16 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -110.12 38.77 3.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.75 153.72 26.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.919 0.39 . . . . 0.0 110.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -134.92 72.69 67.76 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.561 0.696 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 78.84 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.653 2.236 . . . . 0.0 112.345 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -171.6 120.66 0.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -86.45 124.05 32.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.838 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.7 p -85.48 163.69 18.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 141.62 73.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -173.82 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.701 2.267 . . . . 0.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 47.5 t -143.65 166.99 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.6 t -114.56 151.54 33.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.127 -0.819 . . . . 0.0 112.5 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 88.7 p -169.38 119.8 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 65.1 p -89.86 135.46 33.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.835 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -91.37 -176.89 43.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 10.0 t -104.46 -64.76 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 3.8 m 57.81 45.1 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -107.44 -21.7 7.82 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.496 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -167.55 135.79 2.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.88 0.371 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 65.8 p -106.06 104.39 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -170.18 148.32 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.894 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.86 152.9 50.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.52 179.46 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.597 ' CG1' HD22 ' A' ' 370' ' ' LEU . 46.2 t -103.0 143.8 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.124 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -143.16 114.8 8.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.124 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 18.7 t -84.97 112.43 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.33 -26.34 35.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 55.4 mt -52.03 -53.96 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.7 p -105.26 -34.03 8.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.91 72.45 0.98 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -145.9 163.36 35.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.52 120.51 60.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.142 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -107.57 164.77 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -81.23 -58.49 3.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -113.86 163.82 14.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.822 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.647 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.9 t -69.51 -27.74 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -53.16 -38.15 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.963 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -70.61 -27.54 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.597 HD22 ' CG1' ' A' ' 355' ' ' VAL . 32.9 tp -82.93 -34.85 26.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.647 ' OD1' HG12 ' A' ' 367' ' ' VAL . 5.5 m-20 -52.17 -46.49 65.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -79.09 -40.51 31.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -57.96 -29.64 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -63.87 -40.0 95.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 31.9 mt -56.33 -35.17 67.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 50.9 m -64.15 -26.66 68.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -82.94 82.85 8.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.1 m -77.58 -35.5 52.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 143.21 52.22 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.71 130.53 50.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.856 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -130.49 68.88 81.93 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.627 0.727 . . . . 0.0 110.882 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -41.19 4.43 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.71 2.274 . . . . 0.0 112.297 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -105.34 82.87 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 19.2 p -66.39 142.25 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.796 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.8 t -120.56 164.06 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -113.2 75.7 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.468 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.48 0.56 Allowed 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.716 2.277 . . . . 0.0 112.32 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 98.3 p -72.05 101.53 2.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.9 p -59.13 123.57 17.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.837 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.096 -0.836 . . . . 0.0 112.461 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.73 139.19 55.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.0 p -61.62 128.04 34.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -94.0 114.77 4.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.468 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 11.1 p -122.32 144.97 48.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.886 0.374 . . . . 0.0 110.835 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 38.2 m -108.28 -175.98 2.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -72.39 -175.97 27.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.458 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -54.33 116.07 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.924 0.393 . . . . 0.0 110.873 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -103.02 94.69 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -75.75 116.76 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -73.65 93.61 2.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.91 -179.01 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.53 ' CG1' HD22 ' A' ' 370' ' ' LEU . 48.7 t -95.94 140.53 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.18 118.89 13.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.49 115.37 21.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -82.73 -25.89 32.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.78 -52.76 20.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.0 p -108.2 -35.15 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.08 70.74 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -139.58 167.86 21.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.819 0.343 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 41.6 mm -120.18 132.17 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -127.98 158.03 39.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -78.18 -54.42 6.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.88 175.02 5.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.4 t -85.15 -27.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -53.01 -39.43 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -73.53 -29.25 62.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.53 HD22 ' CG1' ' A' ' 355' ' ' VAL . 48.7 tp -74.98 -28.93 60.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -52.95 -61.77 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.613 ' HA ' HD12 ' A' ' 375' ' ' LEU . 28.4 ttp180 -61.09 -27.73 68.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -69.44 -32.51 71.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -69.35 -31.33 69.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.613 HD12 ' HA ' ' A' ' 372' ' ' ARG . 24.6 mt -63.03 -32.15 73.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.9 p -69.11 -33.3 73.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -67.26 129.03 38.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 63.1 m -83.2 165.64 19.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.56 -48.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.467 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -108.12 178.68 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.941 0.4 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -128.61 70.46 80.23 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 92.89 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -153.0 115.88 4.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 96.8 p -65.94 96.63 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 17.0 t -112.94 39.25 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -81.71 -75.43 1.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -175.97 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.713 2.276 . . . . 0.0 112.322 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 87.3 p -105.65 172.32 6.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.29 99.1 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 CA-C-O 119.114 -0.826 . . . . 0.0 112.466 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 91.0 p -67.59 -175.99 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 18.0 m -132.69 56.57 1.84 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -159.8 158.13 29.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.531 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.0 m -122.82 123.38 40.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 66.3 p -146.35 134.87 22.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.02 150.44 7.22 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.451 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 32.27 4.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 44.9 p -75.04 149.5 39.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.188 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 56.15 39.86 30.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 170.1 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -167.09 177.96 5.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.559 HG11 HD22 ' A' ' 370' ' ' LEU . 63.2 t -104.12 143.56 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.57 92.24 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.6 t -52.6 108.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -78.9 -25.31 43.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 80.2 mt -51.61 -57.77 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.9 p -103.93 -33.97 8.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 102.45 61.13 0.73 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.437 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -137.6 141.43 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.751 0.31 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.01 135.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -126.49 156.58 40.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -62.05 -62.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -135.89 178.79 6.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.08 -26.93 37.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -52.07 -30.18 24.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.929 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.84 -33.46 16.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.559 HD22 HG11 ' A' ' 355' ' ' VAL . 18.7 tp -67.28 -40.82 86.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -52.06 -52.64 49.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.508 ' HG2' HD12 ' A' ' 375' ' ' LEU . 0.0 OUTLIER -71.57 -34.96 70.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.872 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -64.07 -27.11 68.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -74.3 -28.59 61.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.508 HD12 ' HG2' ' A' ' 372' ' ' ARG . 99.1 mt -55.38 -27.12 45.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 19.0 t -79.05 -37.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -67.59 173.27 4.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.846 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 30.2 t -85.81 -51.56 6.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.847 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.53 70.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -100.1 37.0 1.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -121.53 71.95 27.89 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.42 10.79 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.708 2.272 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -64.65 152.76 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.42 137.24 52.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.869 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 58.2 p -152.64 135.01 15.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 161.43 -169.86 37.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.478 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 174.27 9.77 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.291 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.3 m -101.79 67.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 12.2 t -135.23 158.22 44.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.135 -0.814 . . . . 0.0 112.491 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 32.9 m -125.62 129.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.903 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 34.0 t -114.18 143.56 44.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 53.5 51.58 47.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.2 t -70.58 147.94 48.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 31.0 m -91.96 114.58 27.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 157.04 171.02 22.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -71.12 102.5 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.6 t -124.86 -39.35 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 -169.13 121.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -100.1 28.38 4.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.89 -179.29 6.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.43 141.25 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 363' ' ' ILE . . . -146.44 137.5 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.0 t -89.64 116.61 27.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -82.55 -24.58 33.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 53.6 mt -51.66 -49.33 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.4 p -115.62 -38.69 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.2 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -148.96 165.09 32.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 356' ' ' ALA . 37.0 mm -122.6 121.14 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.09 -178.06 3.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -94.45 -41.06 9.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.869 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.67 171.74 13.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 86.2 t -76.26 -27.07 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -52.44 -34.07 46.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.57 -34.63 25.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.26 -35.35 80.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.939 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -53.42 -38.38 63.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -79.12 -39.89 32.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -56.01 -39.68 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -60.28 -36.51 78.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 76.1 mt -57.01 -33.8 67.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 40.3 t -68.34 -42.1 79.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -55.55 138.93 45.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 23.3 t -90.12 89.88 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -60.15 166.6 10.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -104.89 35.97 2.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.907 0.384 . . . . 0.0 110.89 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 73.65 0.76 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 157.94 58.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.712 2.275 . . . . 0.0 112.348 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -72.22 130.43 40.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.1 t -97.82 144.66 27.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.806 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.0 t -168.81 146.72 3.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -147.42 172.28 27.85 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 154.75 67.33 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.655 2.237 . . . . 0.0 112.341 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 83.7 p -91.1 86.82 6.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 67.4 p -101.22 123.09 44.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.141 -0.811 . . . . 0.0 112.473 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 16.4 p -104.4 -40.34 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.7 m -84.21 67.4 9.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.848 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -69.56 -113.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 46.2 t -115.57 90.93 3.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 20.3 m -114.33 121.82 44.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -112.17 174.07 16.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -60.93 -60.49 3.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.5 t -157.34 140.96 15.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -66.3 113.62 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 37.76 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.95 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -170.11 169.65 7.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 136.48 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.45 113.24 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -67.08 112.91 4.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -79.92 -23.95 41.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.64 -48.23 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.5 p -118.51 -41.04 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.61 81.65 1.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -148.1 138.66 22.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.7 mm -92.72 121.77 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.21 -178.97 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -102.73 -34.62 8.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -148.71 172.46 14.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 64.1 t -79.04 -27.96 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.55 -27.11 56.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -87.71 -32.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.94 -30.99 68.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.956 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -52.01 -52.4 50.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.911 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -66.73 -27.42 67.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -71.77 -30.78 65.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -64.55 -42.22 95.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 73.9 mt -58.4 -31.6 67.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -34.69 76.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -63.89 164.38 10.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.1 t -107.59 -50.84 3.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.845 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.73 73.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -59.59 116.94 4.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.956 0.408 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -136.24 69.41 62.44 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.534 0.683 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -48.02 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.261 . . . . 0.0 112.333 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -81.35 138.48 35.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.952 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.0 t -116.4 104.88 11.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 33.1 p -106.21 -38.84 6.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -134.36 175.68 20.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.508 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 172.34 12.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.693 2.262 . . . . 0.0 112.339 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 14.0 p -149.49 123.65 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.5 m -82.48 79.02 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.142 -0.81 . . . . 0.0 112.517 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 7.1 t -154.98 148.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.4 t -154.31 121.32 5.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.818 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 131.43 57.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.3 m -67.38 -64.0 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.857 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 2.8 p -98.01 132.39 43.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -68.57 -91.36 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -75.22 76.85 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 t -53.21 -29.04 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.16 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -146.46 139.14 25.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 48.2 mttt -83.66 -69.21 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -75.83 177.42 6.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -91.32 135.42 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.24 97.9 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 15.0 t -65.46 115.3 5.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -85.0 -23.44 28.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.64 -44.82 35.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.126 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 12.1 p -123.06 -38.03 2.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 113.67 60.44 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.55 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.78 158.26 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 28.5 mm -126.02 133.58 68.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -140.15 147.0 39.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.936 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 43.2 ttp85 -65.6 -56.04 14.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -111.75 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.81 -24.67 10.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -51.95 -30.32 24.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -79.33 -33.94 42.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 355' ' ' VAL . 40.8 tp -75.12 -26.29 59.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -53.62 -61.31 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.549 ' HA ' HD12 ' A' ' 375' ' ' LEU . 54.8 ttt180 -64.96 -34.75 79.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.847 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -62.44 -28.95 70.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.83 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -69.7 -37.48 76.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 372' ' ' ARG . 10.2 mt -54.86 -33.21 61.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.0 t -67.53 -43.79 79.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -61.2 173.64 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 5.5 t -126.03 -59.16 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 164.43 -123.14 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -107.25 41.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.91 0.386 . . . . 0.0 110.884 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -133.63 70.93 75.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 172.25 13.06 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -71.94 156.31 39.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 14.2 m -116.27 -49.28 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.804 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.2 m -111.17 176.53 4.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 139.9 74.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -18.08 37.24 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.665 2.244 . . . . 0.0 112.337 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 8.7 t -139.33 123.25 17.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 18.3 m -134.4 -176.65 4.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.47 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.3 t -134.04 142.71 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.843 0.354 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 9.8 t -101.48 116.25 32.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.852 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -93.17 -57.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.523 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 56.84 31.03 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 88.7 p -119.93 -46.84 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.828 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 66.96 -148.06 50.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -171.45 153.06 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.884 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.8 t -135.25 161.51 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -103.27 151.25 22.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -81.05 -25.92 36.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.95 -176.95 4.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.519 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -85.42 139.86 16.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.76 106.31 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.103 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 13.8 t -67.48 115.75 7.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -83.44 -24.57 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.92 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.6 mt -51.69 -49.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.155 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 10.2 p -115.77 -38.82 3.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.95 59.93 0.45 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -121.35 164.47 17.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.733 0.301 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.53 135.82 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -139.37 142.71 37.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -73.22 -50.71 20.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -112.55 166.39 11.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 68.4 t -77.92 -27.55 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -52.3 -31.03 31.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -78.29 -33.24 49.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.519 HD22 HG11 ' A' ' 355' ' ' VAL . 47.1 tp -74.48 -27.2 60.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -53.59 -59.6 4.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -67.61 -35.42 78.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -61.29 -26.29 67.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.854 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -73.02 -41.29 64.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 49.1 mt -55.59 -41.57 73.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.0 m -56.73 -39.38 73.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -64.17 149.66 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -72.55 127.72 33.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.04 166.03 44.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.511 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -90.77 101.45 14.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.884 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -130.74 72.79 81.7 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -179.22 2.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.677 2.252 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -111.87 -47.68 3.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 53.0 p -129.65 125.88 37.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.4 t -89.95 -40.11 12.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 171.89 -169.89 42.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.45 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.48 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.372 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 11.0 t -130.04 121.33 26.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.8 m -119.48 165.49 14.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 119.114 -0.825 . . . . 0.0 112.481 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.5 t -145.52 166.92 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.6 m -122.23 171.3 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -63.37 -29.44 74.54 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 7.6 p -122.86 61.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 110.871 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 41.6 t -55.48 -66.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 174.81 -172.41 45.43 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -121.93 143.45 49.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.932 0.396 . . . . 0.0 110.867 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 34.8 p -133.32 170.09 15.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.194 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -142.69 150.26 39.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.48 24.56 5.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -103.75 168.85 8.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 36.1 t -91.91 138.95 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.089 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -129.6 115.66 17.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.2 t -72.44 100.19 2.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -72.63 -22.28 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.8 mt -51.56 -63.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.5 p -108.58 -35.48 6.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 115.45 75.65 0.62 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.477 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.81 165.46 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.766 0.317 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 36.3 mm -122.87 132.93 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -138.94 150.79 46.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.54 -36.08 17.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -126.3 151.97 46.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 50.4 t -67.4 -26.44 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.154 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -56.92 -28.86 62.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -81.41 -27.02 34.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 56.7 tp -82.19 -29.23 31.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -52.66 -54.15 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -68.58 -34.4 75.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -63.83 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -68.63 -37.56 79.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 54.2 mt -56.92 -42.26 79.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 t -57.6 -43.64 84.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -55.15 135.18 49.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.0 t -99.39 78.2 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.4 113.87 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -52.49 162.93 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.885 0.374 . . . . 0.0 110.894 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -119.67 70.62 13.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.27 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -166.54 -178.55 4.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.8 m -85.35 137.06 33.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.9 p -86.88 -178.77 6.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 177.07 68.19 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.524 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -30.7 21.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.663 2.242 . . . . 0.0 112.314 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 1.3 m 52.13 31.29 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.5 p -146.5 159.5 43.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.473 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.4 m -102.26 165.74 10.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 17.1 m -114.06 150.73 33.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.1 122.12 2.03 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.502 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.4 t -158.82 144.63 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.3 m -84.66 -62.96 1.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -78.18 69.98 2.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.469 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -66.58 -26.89 67.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.389 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 p -64.84 152.43 42.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 47.2 mtm-85 -81.8 154.28 26.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -105.33 -58.42 1.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.92 -177.58 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 370' ' ' LEU . 32.7 t -85.84 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -135.18 102.22 5.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.71 101.87 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -75.91 -21.99 56.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.3 mt -51.63 -57.7 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 22.2 p -112.99 -35.18 5.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 112.14 68.73 0.54 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.65 128.49 29.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 44.0 mm -94.52 143.32 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -146.22 153.08 40.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -58.61 -62.21 2.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.905 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.414 ' C ' HG21 ' A' ' 355' ' ' VAL . 3.6 m-20 -127.0 176.97 6.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.1 t -71.1 -25.23 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -52.06 -33.57 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -84.6 -27.01 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 355' ' ' VAL . 29.6 tp -75.8 -25.88 56.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.896 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -52.02 -63.0 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -59.38 -30.4 68.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -67.05 -37.09 83.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -66.43 -29.99 70.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.6 -32.48 73.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.1 t -70.05 -35.55 74.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.98 157.93 23.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.1 m -123.5 117.5 25.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -97.64 37.72 3.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -61.13 99.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.93 0.395 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -171.39 71.11 0.5 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 159.79 52.09 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -110.5 169.72 8.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.6 t -122.5 102.43 8.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.841 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.4 t -56.48 153.45 10.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 170.46 -70.98 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 137.81 36.27 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.335 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 58.2 m -59.38 179.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 29.7 t -129.81 132.17 46.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.178 -0.79 . . . . 0.0 112.431 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.4 t -68.12 133.24 48.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.89 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 10.5 t -105.91 -29.46 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -168.11 65.63 0.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.1 t -77.55 169.63 17.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.885 0.374 . . . . 0.0 110.856 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 7.0 t -126.05 29.89 5.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -167.41 135.76 3.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.32 120.65 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 69.8 p -112.67 70.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.146 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.85 120.36 14.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.92 -46.64 1.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -57.49 174.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.464 HG11 HD22 ' A' ' 370' ' ' LEU . 39.7 t -107.32 137.92 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -128.95 99.17 5.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.5 t -56.96 99.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.74 -20.96 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 54.4 mt -53.42 -63.91 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.96 -35.97 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 114.03 75.82 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.496 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -140.42 130.94 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.8 mm -90.88 133.14 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -132.13 167.8 19.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -78.79 -61.18 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -128.28 170.13 13.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.97 -32.87 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -52.56 -38.52 60.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 56.3 m170 -73.59 -31.26 63.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 355' ' ' VAL . 45.1 tp -72.68 -29.71 63.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -52.64 -49.93 64.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -69.1 -29.74 67.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -67.18 -38.01 84.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -64.44 -29.31 70.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 86.2 mt -56.37 -43.5 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.5 m -62.63 -42.07 99.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -53.84 -41.75 67.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.2 m -57.01 156.96 6.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 130.43 -82.76 0.32 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.487 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -105.52 41.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.94 0.4 . . . . 0.0 110.901 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -154.99 73.11 5.75 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.608 0.718 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -179.23 2.78 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.282 . . . . 0.0 112.324 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -93.16 139.12 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.4 m -90.34 137.37 32.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 47.4 m -88.89 115.74 26.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.29 72.06 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.508 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 0.0 112.358 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 88.2 p -107.38 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.6 p -81.46 83.59 6.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.504 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 28.8 m -118.75 161.26 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.375 . . . . 0.0 110.872 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 13.1 p -139.24 165.52 26.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -165.25 63.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.483 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 12.3 p -111.45 127.45 55.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 0.0 110.866 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 68.7 p -76.42 173.6 11.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.865 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -147.31 84.88 0.17 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -94.13 115.04 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.7 t -123.38 147.53 46.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -70.58 146.9 49.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -88.06 96.5 10.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -123.79 173.79 7.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.64 HG11 HD22 ' A' ' 370' ' ' LEU . 48.1 t -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.33 95.69 3.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.093 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 25.5 t -60.8 116.87 4.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 -26.32 22.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 78.9 mt -51.83 -48.71 38.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.122 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.1 p -111.93 -31.23 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 98.88 71.14 0.99 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.35 166.07 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.721 0.296 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 38.1 mm -121.64 142.83 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.073 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -133.68 176.26 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -99.75 -39.35 8.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -133.64 179.27 6.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.4 t -87.83 -26.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -53.8 -30.24 43.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.917 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -84.15 -26.68 28.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.64 HD22 HG11 ' A' ' 355' ' ' VAL . 28.5 tp -76.2 -28.69 57.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -53.99 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.87 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 33.1 ttp180 -62.08 -30.46 71.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.3 -34.56 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.25 -32.92 70.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.73 -35.7 81.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.897 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -65.8 -37.48 86.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.827 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -62.88 159.97 15.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.4 t -76.31 150.48 36.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.16 156.55 19.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -93.55 90.13 6.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.929 0.395 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -55.61 160.67 3.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.623 0.725 . . . . 0.0 110.9 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 103.38 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.698 2.266 . . . . 0.0 112.367 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -53.06 147.91 8.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.2 m -66.42 134.7 53.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 23.4 t -94.46 103.06 15.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -60.06 174.47 4.54 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 177.1 5.93 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 15.0 p -69.73 -178.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 14.3 m -148.51 126.03 11.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 CA-C-O 119.104 -0.831 . . . . 0.0 112.469 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.5 t -85.37 85.21 7.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.845 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 52.86 55.77 8.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 79.5 61.77 2.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 2.8 m -70.17 104.45 2.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.911 0.386 . . . . 0.0 110.898 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.5 p -158.82 152.73 23.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -101.41 163.24 17.8 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -79.64 -26.24 41.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 8.2 p -85.41 122.08 29.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -131.82 141.18 49.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 47.77 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -165.83 176.89 7.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.689 HG11 HD22 ' A' ' 370' ' ' LEU . 29.1 t -106.74 144.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -133.71 103.01 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 12.9 t -68.61 113.37 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.14 -26.28 31.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 75.7 mt -51.94 -53.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 24.5 p -106.23 -34.31 7.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 100.41 66.94 0.82 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -140.63 169.09 18.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.28 144.09 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -136.61 160.73 37.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -65.08 -57.72 7.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -145.56 -179.53 6.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 32.9 t -64.15 -27.0 41.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -56.27 -37.05 69.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -82.36 -26.28 33.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.689 HD22 HG11 ' A' ' 355' ' ' VAL . 30.0 tp -76.5 -30.09 57.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -52.4 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -70.3 -34.75 73.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -64.24 -32.18 73.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -72.18 -34.88 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 81.7 mt -55.61 -27.25 48.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.0 t -84.16 -31.1 25.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -70.96 99.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -165.57 160.33 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -112.08 92.66 0.65 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.521 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -84.46 -60.49 2.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.923 0.392 . . . . 0.0 110.898 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.2 160.65 0.12 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 110.891 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 130.43 19.41 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.336 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -114.4 159.82 19.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.933 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.4 t -172.18 130.83 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 61.5 m -121.06 176.44 5.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 147.46 -70.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 95.13 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.75 2.3 . . . . 0.0 112.313 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.6 157.22 47.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.4 m -123.23 112.72 18.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.168 -0.796 . . . . 0.0 112.436 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 73.5 m -69.49 138.28 53.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.913 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 2.2 m -94.84 -62.4 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 151.47 -57.27 0.44 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 45.3 t -78.08 153.08 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 110.876 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 49.1 p -67.46 -43.49 80.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 145.97 -109.6 0.5 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -77.09 118.16 19.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.911 0.386 . . . . 0.0 110.883 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.9 p -88.52 -54.55 4.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.58 48.81 20.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -66.38 -30.79 71.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -106.68 -178.67 3.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.648 HG11 HD22 ' A' ' 370' ' ' LEU . 23.1 t -107.96 149.46 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.74 115.87 11.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 22.0 t -80.91 116.51 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -84.82 -26.25 27.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 67.7 mt -52.2 -53.02 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.92 -31.55 8.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.6 64.58 0.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -138.05 170.56 15.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 mm -119.07 143.33 30.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -135.57 147.18 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -57.33 -59.87 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -133.71 -178.22 4.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.577 HG12 ' OD1' ' A' ' 371' ' ' ASN . 21.8 t -72.14 -28.65 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -53.48 -28.62 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -88.1 -26.45 22.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.648 HD22 HG11 ' A' ' 355' ' ' VAL . 21.4 tp -79.55 -26.03 41.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.577 ' OD1' HG12 ' A' ' 367' ' ' VAL . 64.2 m-20 -56.04 -53.85 52.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -39.0 72.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -55.63 -42.2 74.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.9 -36.41 72.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 41.3 mt -56.82 -33.92 67.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.1 p -68.89 -30.22 68.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -78.64 158.07 28.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.8 t -143.49 147.5 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.22 82.99 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -94.39 135.43 35.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.944 0.402 . . . . 0.0 110.903 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -103.79 160.66 25.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.515 0.674 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 164.26 35.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.667 2.245 . . . . 0.0 112.37 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -161.06 145.35 13.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 18.2 p -141.13 144.92 35.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 45.5 m -134.64 166.54 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.852 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -63.22 -178.17 4.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 158.67 56.09 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.249 . . . . 0.0 112.305 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 7.7 t -143.1 131.29 21.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.851 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 55.1 m -67.22 104.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.84 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.504 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 6.9 m -80.36 148.69 30.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.849 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.7 t -127.24 75.25 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 138.37 118.35 1.63 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.1 m -116.49 113.75 23.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.917 0.389 . . . . 0.0 110.836 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 72.9 m -159.62 157.26 29.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 70.87 -170.96 45.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -113.06 176.52 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.9 p -120.12 42.87 2.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.121 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -128.85 83.48 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.01 107.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -145.15 176.66 9.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . . . . . . . . . 22.7 t -107.01 144.06 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.155 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -134.76 100.01 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.096 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.28 101.61 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.52 -26.36 63.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.07 -71.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 27.7 p -83.66 -31.55 26.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 95.7 68.65 1.01 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -148.62 156.06 41.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.81 139.57 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -127.84 179.23 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 67.3 mmt-85 -85.89 -62.54 1.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -134.97 172.67 12.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 23.2 t -65.67 -25.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -53.35 -33.98 55.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.79 -30.8 24.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.0 tp -70.5 -26.13 63.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -54.25 -63.66 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -65.59 -37.37 86.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -57.3 -37.11 71.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -65.13 -37.05 86.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . . . . . . . . . 97.0 mt -58.24 -33.16 69.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.9 t -67.62 -36.19 80.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -63.5 140.16 58.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 137.15 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.829 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 156.43 -167.14 33.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.479 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -74.52 155.5 37.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -105.44 160.66 25.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.528 0.68 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -174.17 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.721 2.281 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -118.53 162.29 18.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.9 t -90.9 143.61 26.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 42.0 m -126.44 139.4 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.79 170.16 43.51 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 142.44 47.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.306 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 49.3 m -136.22 178.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 5.0 t -161.5 112.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.513 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 64.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 88.1 p -174.48 133.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 141.33 162.23 9.05 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 4.4 m -132.49 128.39 37.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 1.2 p -94.53 -48.67 6.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -146.38 -161.27 9.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 56.6 53.72 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 2.9 m -110.1 42.83 1.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -160.66 138.77 9.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -115.56 -74.32 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.89 173.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.541 HG11 HD22 ' A' ' 370' ' ' LEU . 21.8 t -90.87 135.43 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -132.05 96.42 3.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 11.1 t -62.09 96.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.42 -22.95 63.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 58.0 mt -51.63 -71.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.1 p -99.29 -33.08 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 108.95 75.14 0.85 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -141.74 132.65 25.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.741 0.305 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 42.2 mm -98.03 140.58 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -137.78 173.83 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -82.49 -59.05 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.15 177.0 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.82 -30.02 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -53.65 -32.6 52.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -80.01 -28.67 39.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.541 HD22 HG11 ' A' ' 355' ' ' VAL . 31.9 tp -77.83 -28.21 50.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -52.12 -60.72 2.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 375' ' ' LEU . 33.1 ttt180 -62.53 -31.17 71.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -74.36 -37.16 63.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 372' ' ' ARG . 73.6 mt -53.07 -29.49 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 14.5 t -74.06 -33.6 63.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -68.76 163.37 24.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.1 m -95.34 153.0 17.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.58 36.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.493 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.54 84.57 2.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -98.73 160.68 27.29 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.556 0.694 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 111.82 2.92 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.693 2.262 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -111.77 26.31 10.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 22.9 t -126.69 143.98 51.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.8 m -80.9 148.08 30.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.86 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -139.12 -75.43 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -43.56 2.51 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 2.3 t -156.67 147.99 22.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.4 m -96.3 96.44 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 CA-C-O 119.079 -0.845 . . . . 0.0 112.485 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 29.1 t -145.89 130.55 17.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 49.3 m -71.96 -66.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 175.97 124.77 0.84 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.446 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 38.1 m -71.53 -60.32 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.82 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 23.1 t -166.78 129.73 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -143.22 -151.75 5.54 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 104.29 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.912 0.386 . . . . 0.0 110.883 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.0 m -126.71 108.34 10.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.144 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -110.97 87.47 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.03 143.23 55.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -128.81 178.12 6.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.598 ' CG1' HD22 ' A' ' 370' ' ' LEU . 28.1 t -101.35 136.36 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.29 10.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 8.6 t -61.14 117.31 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.74 15.5 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 84.6 mt -95.86 -46.51 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 7.4 p -118.47 -41.63 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 118.54 77.15 0.55 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -150.43 144.83 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.0 110.859 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 39.5 mm -100.22 145.74 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.146 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -130.11 -179.79 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -100.95 -32.16 10.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -149.21 -179.64 7.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 61.0 t -84.16 -31.08 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -56.72 -39.75 74.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -76.34 -26.22 55.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.598 HD22 ' CG1' ' A' ' 355' ' ' VAL . 30.4 tp -79.04 -27.79 43.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -57.94 -38.03 75.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.78 ' HA ' HD12 ' A' ' 375' ' ' LEU . 9.4 tpp85 -76.9 -26.18 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.53 -56.41 16.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.81 -32.18 60.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 372' ' ' ARG . 62.5 mt -64.11 -25.97 68.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 11.8 t -83.83 -31.3 25.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -52.05 164.3 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -72.02 156.9 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -58.09 164.78 7.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -96.27 165.04 12.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.49 68.91 9.39 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.92 3.28 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.723 2.282 . . . . 0.0 112.328 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -145.74 112.42 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.943 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 m 60.35 46.94 9.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.837 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 12.9 t -141.5 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -141.74 70.94 0.42 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.471 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 126.92 13.83 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.687 2.258 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 43.6 p -130.48 50.58 2.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.7 p -53.05 -64.41 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.147 -0.807 . . . . 0.0 112.449 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 8.5 m -92.74 -43.62 8.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 70.1 m -103.9 75.91 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . 160.78 -128.87 2.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.2 m 56.52 45.03 23.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.848 0.356 . . . . 0.0 110.839 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' SER . . . . . . . . . . . . . 4.3 t -99.16 -30.32 12.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 69.76 -155.21 53.24 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.444 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -61.47 120.95 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 3.4 t -108.63 -33.49 7.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.184 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -92.22 167.45 12.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.57 -28.8 7.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' GLN . . . . . 0.419 ' H ' ' NE2' ' A' ' 354' ' ' GLN . 1.1 pm0 -135.57 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' VAL . . . . . 0.705 HG11 HD22 ' A' ' 370' ' ' LEU . 47.7 t -90.32 146.52 6.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -138.84 103.93 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.113 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' CYS . . . . . . . . . . . . . 19.6 t -65.5 117.22 7.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -26.31 22.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 74.6 mt -52.2 -49.01 42.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 29.2 p -111.02 -29.42 7.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.03 67.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -138.01 167.33 22.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.75 0.31 . . . . 0.0 110.928 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 46.2 mm -119.13 141.22 40.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.155 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -136.95 136.79 38.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . . . . . . . . . 13.8 ttt-85 -52.54 -52.9 52.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -134.17 -177.94 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 56.4 t -73.86 -25.56 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -52.13 -36.48 51.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.92 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -80.23 -26.68 38.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.705 HD22 HG11 ' A' ' 355' ' ' VAL . 46.0 tp -75.48 -30.36 59.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -54.55 -70.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.804 ' HA ' HD12 ' A' ' 375' ' ' LEU . 53.7 ttt180 -59.26 -26.4 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -67.16 -46.32 74.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -64.15 -35.74 81.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 372' ' ' ARG . 29.8 mt -55.91 -26.68 48.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.3 t -77.27 -41.76 39.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.832 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -54.63 143.33 25.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 2.0 p -122.1 165.85 15.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -159.71 144.87 10.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.478 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.57 157.45 20.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.895 0.379 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -128.62 159.32 68.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.611 0.719 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 153.52 68.67 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 0.0 112.333 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -70.87 149.65 46.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 2.0 p -131.16 95.74 3.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.6 t -98.56 124.38 43.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 154.1 173.63 23.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 123.57 10.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.672 2.248 . . . . 0.0 112.315 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' SER . . . . . . . . . . . . . 3.4 p -101.73 91.0 4.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.868 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.5 m -143.37 138.45 29.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.474 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_